Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

The document highlights a stark vaccine inequity between Africa and the EU, noting that as of January 2022, Africa's population vaccination rate was only 10.2% compared to 72% in the EU.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • As of January 26, 2022, cumulative COVID-19 cases per 1 million population were nearly 25 times higher in the European Union than in Africa, with 81.2 million cases in the 27 EU countries compared to 10.7 million in 54 African countries.
  • The World Health Organization (WHO) estimates that only about 14.2% (one in seven) of COVID-19 infections are being detected in Africa, suggesting the pandemic's impact there may be greatly underestimated.
  • There is significant vaccine inequity: as of January 27, 2022, the fully vaccinated population rate in Africa was 10.2%, while the EU reached 72%. Only seven of 54 African countries met the 2021 year-end WHO target of fully vaccinating 40% of their people.
  • Africa is heavily dependent on imports for vaccines, importing approximately 99% of its routine vaccine needs, primarily from manufacturers in India such as Bharat Biotech, BioMed, and the Serum Institute of India.
  • African vaccine manufacturing capacity is currently very limited, with only 10 local value chain players operating in Nigeria, South Africa, Algeria, Egypt, Ethiopia, Morocco, Senegal, and Tunisia; 40% only engage in packaging and labelling and 40% only in fill and finish.
  • The Partnership for African Vaccine Manufacturing (PAVM) aims for a 2040 roadmap to produce 100% of vaccines for 1-3 emerging diseases, 30-60% of vaccines for a pandemic, and 60% of annual routine vaccine needs locally.
  • Distribution bottlenecks in Africa include a shortage of specialized health workers, lack of basic equipment like 0.3ml syringes for Pfizer doses, vaccine hesitancy, and 'last mile' challenges reaching rural communities due to cold chain requirements.

Cite the original document

APA
Africa-Europe Foundation (2022). Africa and Europe Facts and Figures on COVID-19 Vaccination. https://back.africaeuropefoundation.org/uploads/AEF_Summit_Vaccines_FINAL_c60a19b9a8.pdf
Chicago
Africa-Europe Foundation. Africa and Europe Facts and Figures on COVID-19 Vaccination. 2022. https://back.africaeuropefoundation.org/uploads/AEF_Summit_Vaccines_FINAL_c60a19b9a8.pdf.
Wikipedia
{{cite report |author=Africa-Europe Foundation |title=Africa and Europe Facts and Figures on COVID-19 Vaccination |date=26 January 2022 |url=https://back.africaeuropefoundation.org/uploads/AEF_Summit_Vaccines_FINAL_c60a19b9a8.pdf |access-date=5 November 2026 |via=Climate Insights Directory (document afreurfn-000084)}}
BibTeX
@techreport{africaeuropefoundation2022africa, author = {{Africa-Europe Foundation}}, title = {{Africa and Europe Facts and Figures on COVID-19 Vaccination}}, institution = {Africa-Europe Foundation}, year = {2022}, month = jan, url = {https://back.africaeuropefoundation.org/uploads/AEF_Summit_Vaccines_FINAL_c60a19b9a8.pdf}, urldate = {2026-11-05}, note = {Indexed by Climate Insights Directory, document afreurfn-000084} }

Full text

Collected · Record updated